Drug Discovery With Cryptic Metabolites
Cryptyx Bioscience is a Princeton, NJ biotechnology company developing a novel small-molecule drug discovery platform based on High-Throughput Elicitor Screening (HiTES). The platform provides a rapid, efficient approach for activating silent biosynthetic gene clusters in microorganisms to unearth cryptic metabolites — potential drug leads that cannot be accessed with existing technologies, without requiring genome sequencing, cloning, or genetics. NSF SBIR Phase I and Phase II awardee.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
